Biogena Group Invest AG (WBO:BIO) COGS-to-Revenue : 0.01 (As of Jan. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Biogena Group Invest AG COGS-to-Revenue?

Biogena Group Invest AG's Cost of Goods Sold for the six months ended in Jan. 2024 was €0.00 Mil. Its Revenue for the six months ended in Jan. 2024 was €0.17 Mil.

Biogena Group Invest AG's COGS to Revenue for the six months ended in Jan. 2024 was 0.01.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Biogena Group Invest AG's Gross Margin % for the six months ended in Jan. 2024 was 99.40%.

Biogena Group Invest AG COGS-to-Revenue Historical Data

The historical data trend for Biogena Group Invest AG's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biogena Group Invest AG COGS-to-Revenue Chart

Biogena Group Invest AG Annual Data

Trend

Jan21

Jan22

Jan23

Jan24

COGS-to-Revenue

0.01

Biogena Group Invest AG Semi-Annual Data
	Jan21	Jan22	Jan23	Jan24
COGS-to-Revenue	-	-	-	0.01

Biogena Group Invest AG COGS-to-Revenue Calculation

Biogena Group Invest AG's COGS to Revenue for the fiscal year that ended in Jan. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0.001	/	0.166
	=	0.01

Biogena Group Invest AG's COGS to Revenue for the quarter that ended in Jan. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0.001	/	0.166
	=	0.01

Biogena Group Invest AG (WBO:BIO) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Biogena Group Invest AG's Gross Margin % for the six months ended in Jan. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0.001 / 0.166
	=	99.40 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Biogena Group Invest AG COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Biogena Group Invest AG's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Biogena Group Invest AG (WBO:BIO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Biogena Group Invest AG (WBO:BIO) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

Strubergasse 24, Salzburg, AUT, 5020

Website

https://www.biogenagroup.com

Biogena Group Invest AG is a holding company. It is engaged in the development and distribution of products and services in the field of health and nutrition. In particular, the focus is on iron, mineral and osteoporosis product innovations and new integrated solutions in the area of workplace health promotion. Its products include vitamin, mineral, enzymes, medicinal mushrooms, among others.